Ser309
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.5.9.3
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser309  -  SMAD3 (mouse)

Site Information
EVFAECLsDSAIFVQ   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 1243501

In vivo Characterization
Methods used to characterize site in vivo:
mass spectrometry ( 1 ) , western blotting ( 1 )
Relevant cell line - cell type - tissue:
heart ( 1 )

Upstream Regulation
Putative in vivo kinases:
PKG1 (mouse) ( 1 )
Treatments:
KT5823 ( 1 ) , TGF-beta ( 1 )

Downstream Regulation
Effects of modification on SMAD3:
activity, induced ( 1 ) , intracellular localization ( 1 )

References 

1

Li P, et al. (2008) Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts. Circ Res 102, 185-92
17991884   Curated Info